Science Parks, Research Centres & Incubators
Visualisation of the Panum complex in Copenhagen Science City, by MIR.
CAPNOVA is an investment and development company that turns the ideas of innovative entrepreneurs into successful businesses by investing governmental, regional and own venture capital.
Read more about CAPNOVA
CAT Science Park
CAT provides office space with other start-up organisations, to build an entrepreneurial environment. Based in Roskilde, the offices are adjacent to CAPNOVA, an investment fund, giving advice and guidance on the growth of developing businesses. The park has around 2000m2 of office space, shared by organisations from various industries. This allows the inter-disciplinary exchange of ideas and experiences within the park.
Read more about CAT Science Park
Copenhagen Bio Science Park
COBIS is a hub for biotech organisations to grow and develop. The newly built 12,000 square meters park host’s offices, international standard laboratory equipment, and conference and meeting space. It is home to start ups, midsize organisations and technology professionals.
Read more about COBIS
The centre comprises a wide range of expertise and skills within its research programs spanning disease systems biology, proteomics, high-throughput protein production and characterisation, chemical biology, disease biology, and protein therapeutics.the aim is to identify commercially interesting compounds which have the ability to speed up the strain design process for biopharmaceutical cell factories.
Read more about DTU Biosustain
DTU Nanotech is a department at DTU, dedicated to conduct research, education and innovation within micro- and nanotechnology at the highest international level. They have four main research areas, one of which being Biomedical and Lifescience.
Read more about DTU Nanotech
Ideon Innovation is one of Europe’s most powerful incubator programmes. It helps entrepreneurs and innovators from academia, research institutes and industry transform their ideas into competitive businesses.
Read more about Ideon Innovation
Ideon Science Park
Ideon Science Park in Lund is the first Science Park founded in Sweden, and remains the largest in Scandinavia, with over 300 companies and about 2,500 employees.
Read more about Ideon Science Park
Krinova Science Park
Krinova Science Park is located adjacent to the Kristianstad University. It features well-equipped facilities and a number of outreach activities in order to encourage creativity in large and small companies alike. Krinova is uniquely placed to assist companies in developing their business models in environmental sciences, food sciences and human resources.
Read more about Krinova Science Park
LU Bio is also a Lund University initiative in collaboration with private investors. It brings valuable life science research discoveries to investors who have the commercial know-how to start-up a successful business.
Read more about LU Bio
LU Innovation System
This is Lund University’s technology transfer office. LU Innovation System helps researchers commercialise their ideas.
Read more about LU Innovation System
The Lundbeck foundation have invested heavily in establishing many research centres at Copenhagen University. These cover a broad range of scientific areas, pertaining to different diseases. These research groups are; Asthma in Childhood, Biomembranes in Nanomedicine, Neuropsychiatric diseases, The Lundbeck Foundation Centre for Neurovascular Signaling, Brain Barrier research.
Located at Medicon Village in Lund, SmiLe Incubator helps entrepreneurs and start-up life science companies to develop and commercialise their products and services. Its goal is to create several successful life science companies and job opportunities in the region, ultimately to the benefit of the region.
Read more about SmiLe Incubator
Medeon Science Park
Medeon in Malmö focuses entirely on life science: biotechnology, health sciences, medical technology and pharmaceuticals. The facilities provide support through tutoring and coaching in the industry standards.
Read more about Medeon Science Park
Medicon Village offers a unique environment for the growth of development intensive companies and knowledge base within the fields of biotechnology, pharmaceutical, medical devices, diagnostics and healthcare companies.
Read more about Medicon Village
Malmö Incubator is the creative hotspot for meetings between young entrepreneurs, venture capital, industry, commerce, research & innovation.
Read more about MINC
Novo Nordisk Foundation Research Centres
DanStem (co founded by Danish Council for Strategic Research) - KU
DanStem, following investments from NovoNordisk and DCSR, is a research group focussed insulin producing beta cells and cancer research already located at the University of Copenhagen.
Novo Nordisk foundation Centre for Metabolic research - KU
The Novo Nordisk Foundation Centre for Basic Metabolic Research is a centre of bringing scientific discoveries from the laboratory to the society in an effort to tackle some of today’s biggest challenges – diabetes and obesity. The close interdisciplinary collaboration between more than 100 skilled scientists enables more effective discovery strategies to prevent, control and, ultimately cure metabolic diseases.
Novo Nordisk Foundation Centre for Protein research – KU
The Novo Nordisk Foundation Centre for Protein Research was established in 2007 at the Faculty of Health and Medical Sciences, University of Copenhagen, to promote basic and applied discovery research on human proteins of medical relevance. The centre comprises a wide range of expertise and skills within its research programs spanning disease systems biology, proteomics, high-throughput protein production and characterisation, chemical biology, disease biology, and protein therapeutics.
The Centre for Basic and Translational Neuroscience – KU
The centre for Basic and Translational Neuroscience focuses on the development of new approaches for treating neurological diseases, primarily using cell and gene therapy. The focus is on using these technologies to mobilise endogenous stem and progenitor cells of the adult brain and spinal cord, as a means of structural repair.
Started in 2002, PULS is the bridge between innovators and the pharmaceutical industry ensuring the optimisation of value in life science. It acts as an incubator and investor for projects by engaging early with innovators to attain an optimal IP platform and high quality development throughout the process.
Read more about PULS
Scion DTU Science and Technology Park hosts its high tech facilities in Lyngby, Copenhagen. It is located next to the technical university of Denmark (DTU) and the 19 research-intensive institutes within it.
Read more about Scion DTU
Symbion is based in Copenhagen and creates a leading entrepreneurial environment. They currently have a large network of over 250 entrepreneurs and small companies working on areas such as IT, life sciences and cleantech. Symbion work in partnership with Scion DTU and COBIS to create the best environment for science focused organisations.
Read more about Symbion
The Danish e-Infrastructure Cooperation
The DeIC National LifeScience HPC and Datacenter is a collaboration between DeIC, the Technical University of Denmark and the University of Copenhagen.
The supercomputer serves all life science research groups within Denmark and is also open for international collaboration. This supercomputer known as Computerome fulfills the high demands life science research places on computational resources.
Read more about the Danish e-Infrastructure Cooperation
The Danish Elixir Node
The Elixir Node aims to provide high-level support to Danish stakeholders in the fields of biology,systems biology, biotechnology and medicine. These can be from academia or industry - and are aided with the tools and data services for users with and without special competences.
Read more about the Danish Elixir Node
European Spallation Source ERIC and Max IV
The European Spallation Source ERIC (ESS) is a Partnership of 15 European nations committed to the goal of collectively building and operating the world’s leading facility for research using neutrons.
To succeed in its mission ESS relies on the expertise of its Partners from across Europe, and other areas around the globe. ESS has a large network of laboratories to exchange knowledge, personnel and experience with, and that in many cases will contribute directly to the project through In-Kind Contributions.
The facility is currently under construction in Lund, Sweden. However, when the ESS User Program begins in 2023, an estimated two to three thousand visiting scientists will come to ESS annually to perform experiments. Most users will be based at European universities and institutes, and others within Industry.
MAX IV Laboratory is the latest synchrotron facility inaugurated in June 2016. It is the brightest x-ray equipment available to scientists from academia and industry in the whole world. The 2 facilities can together bring the material science research on electrolyzers to the next level by making the invisible visible.
The X-rays will be used to understand, explain and improve the world around us. They will enable the study of materials that we use today and improve them beyond the performance that we know. The ESS will be of great importance in pre-clinical research within life science. Within the life science industry, neutrons and the neutron scattering techniques and methods are becoming a tool of choice in the understanding of drug delivery mechanisms and the early drug delivery and characterization.
When in operation ESS and MAX IV will be the world leading synchrotron facility. It is however not the first, as two other projects have been completed in Japan and the US. At the Japanese facility, SPring-8, scientists recently discovered what they believe could solve the myth of bacterial drug resistance.
Today antibiotics are commonly used to kill bacteria, but recently it has proven less effective due to drug resistance (Press release: New Protein Discovery Solves Myth of Bacterial Drug Resistance).
At the US facility Argonne National Laboratory, one of the most successful drugs were invented, stopping the progress of HIV. Today researchers study how viruses interact with cells. This information could help researchers to design drugs to block or reduce those interactions and hopefully cure HIV or extend more lives in the future (Four Examples Of Industry Gaining An Edge By Using Argonne Facilities).
Read more about MAX IV and European Spallation Source ERIC